lifestyle.newsblaze.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Creative Realities Announces Repurchase of Slipstream Warrants

    Creative Realities Announces Repurchase of Slipstream Warrants

    Creative Realities
    February 18, 2026
  • ModelOp Appoints Dave Trier to CEO As It Enters Next Phase of Growth

    ModelOp Appoints Dave Trier to CEO As It Enters Next Phase of Growth

    ModelOp, Inc.
    February 18, 2026
  • Nayax Announces Global Partnership with DC Fast Charger OEM Tritium to Simplify EV Charger Payment Enablement

    Nayax Announces Global Partnership with DC Fast Charger OEM Tritium to Simplify EV Charger Payment Enablement

    Nayax Ltd.
    February 18, 2026
  • Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

    Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

    Knight Therapeutics
    February 18, 2026
  • QGold Reports Results from Its Drilling Campaigns at Its Mine Centre Gold Project

    QGold Reports Results from Its Drilling Campaigns at Its Mine Centre Gold Project

    Q-GOLD RESOURCES LTD.
    February 18, 2026
  • Exco Technologies Limited Announces Normal Course Issuer Bid

    Exco Technologies Limited Announces Normal Course Issuer Bid

    Exco Technologies Ltd.
    February 18, 2026
  • Nexxen to Announce Fourth Quarter 2025 Financial Results on March 4, 2026

    Nexxen to Announce Fourth Quarter 2025 Financial Results on March 4, 2026

    Nexxen International Ltd.
    February 18, 2026
  • LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE

    LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE

    Lazard Frères & Co. LLC
    February 18, 2026
  • RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

    RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

    Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates
    February 18, 2026
  • HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger

    HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger

    Global Think Group
    February 18, 2026
Prev
1 … 7,572 7,573 7,574 7,575 7,576 … 30,444
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.